Epril
Epril is a medicine authorised by Swissmedic under authorisation number 55229. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 January 2000 and the authorisation is valid without a time limit. ATC code C09AA02 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 55229 |
|---|---|
| Name | Epril |
| Full name | Epril, Tabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09AA02 |
| First authorisation | 25 January 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Epril, Tabletten | B | 25 January 2000 |
| 2 | Epril mite, Tabletten | B | 25 January 2000 |
| 3 | Epril submite, Tabletten | B | 25 January 2000 |
| 4 | Epril 40, Tabletten | B | 27 April 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 30 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 4 | 100 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 6 | 30 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 8 | 100 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 10 | 30 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 12 | 30 | Tablette(n) | C09AA02 | 02.07.1. | B |
| 14 | 100 | Tablette(n) | C09AA02 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Epril authorised in Switzerland?
Yes. Epril is authorised by Swissmedic under authorisation number 55229, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Epril have?
Epril is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Epril?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.